Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy

Condition:   Membranous Nephropathy Intervention:   Drug: Peginterferon Alfa-2A 180 MCG/ML Injectable Solution Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials